Neuchatel based Novostia raises CHFF 6.5 million
07.03.2019
Share this article
The funds, raised from private investors, will support Novostia in carrying out the first clinical trials.
Novostia has developed, in collaboration with Microcity, the University of Bern and the EPFL, a new generation of artificial heart valves.